Mr Richard Jackson BSc, MSc

Medical Statistician Clinical Directorate Professional Services

    Publications

    2020

    Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria (Journal article)

    Daly, A., Evans, S., Pinto, A., Jackson, R., Ashmore, C., Rocha, J. C., & MacDonald, A. (2020). Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria. NUTRIENTS, 12(8). doi:10.3390/nu12082443

    DOI: 10.3390/nu12082443

    2019

    The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial (Journal article)

    Daly, A., Evans, S., Chahal, S., Santra, S., Pinto, A., Gingell, C., . . . MacDonald, A. (2019). The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial. NUTRIENTS, 11(3). doi:10.3390/nu11030520

    DOI: 10.3390/nu11030520

    2018

    Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial (Journal article)

    Sharp, A., Cornforth, C., Turner, M. A., Harrold, J., Kenny, L. C., Jackson, R., . . . Alfirevic, Z. (2018). Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial. Lancet Child and Adolescent Health, 2(2), 93-102. doi:10.1016/S2352-4642(17)30173-6

    DOI: 10.1016/S2352-4642(17)30173-6

    2017

    Diagnostic accuracy of individual antenatal tools for prediction of small-for-gestational age at birth (Journal article)

    Poljak, B., Agarwal, U., Jackson, R., Alfirevic, Z., & Sharp, A. N. (2017). Diagnostic accuracy of individual antenatal tools for prediction of small-for-gestational age at birth. Ultrasound in Obstetrics and Gynecology, 49(4), 493-499. doi:10.1002/uog.17211

    DOI: 10.1002/uog.17211

    Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials (Journal article)

    Jackson, R., Psarelli, E. E., Berhane, S., Khan, H., & Johnson, P. J. (2017). Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials. Journal of Clinical Oncology, 35(6), 622-628. doi:10.1200/JCO.2016.69.5197

    DOI: 10.1200/JCO.2016.69.5197

    Impact of viral status on survival in patients receiving sorafenib for advanced hepatocellular cancer: A meta-analysis of randomised phase III trials (Journal article)

    Johnson, P. J., Jackson, R., Berhane, S., & Psarelli, E. (2017). Impact of viral status on survival in patients receiving sorafenib for advanced hepatocellular cancer: A meta-analysis of randomised phase III trials. Journal of Clinical Oncology. doi:10.1200/JCO.2016.69.5197

    DOI: 10.1200/JCO.2016.69.5197

    2015

    What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses (Journal article)

    Sultana, A., Jackson, R., Gilbert, T., Bostock, E., Psarelli, E., Cox, T., . . . Halloran, C. (2015). What Is the Best Way to Identify MalignantTransformation Within Pancreatic IPMN: A SystematicReview and Meta-Analyses. Clinical and Translational Gastroenterology, 6(12), e130. doi:10.1038/ctg.2015.60

    DOI: 10.1038/ctg.2015.60

    VICTOR: Vinflunine (Vin) in advanced metastatic transitional cell carcinoma of the urothelium (TCCU)-A retrospective analysis of use of Vin in multicenter, real life setting as second-line chemotherapy (ChT) through free-of charge-programme (FOCP) for patients (pts) in the UK (Conference Paper)

    Hussain, S. A., Ansari, J., Huddart, R. A., Wylie, J., Vilarino-Varela, M., Faust, G., . . . Jackson, R. (2015). VICTOR: Vinflunine (Vin) in advanced metastatic transitional cell carcinoma of the urothelium (TCCU)-A retrospective analysis of use of Vin in multicenter, real life setting as second-line chemotherapy (ChT) through free-of charge-programme (FOCP) for patients (pts) in the UK. In JOURNAL OF CLINICAL ONCOLOGY Vol. 33. doi:10.1200/jco.2015.33.7_suppl.352

    DOI: 10.1200/jco.2015.33.7_suppl.352

    Adjuvant Therapy in Pancreatic Cancer (Journal article)

    Oldfield, F., Ghaneh, P., Jackson, R., & Halloran, C. (n.d.). Adjuvant Therapy in Pancreatic Cancer. International Journal of Digestive Diseases, 01(01). doi:10.4172/2472-1891.100003

    DOI: 10.4172/2472-1891.100003

    Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac. (Journal article)

    Nicholson, J., Greenhalf, B., Jackson, R., Cox, T., Butler, J., Hanna, T., . . . Neoptolemos, J. (2015). Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac.. Pancreas, 44(02), 260-265. doi:10.1097/MPA.0000000000000246

    DOI: 10.1097/MPA.0000000000000246

    2014

    Adjuvant therapy in pancreatic cancer (Journal article)

    Jones, O. P., Melling, J. D., & Ghaneh, P. (2014). Adjuvant therapy in pancreatic cancer. WORLD JOURNAL OF GASTROENTEROLOGY, 20(40), 14733-14746. doi:10.3748/wjg.v20.i40.14733

    DOI: 10.3748/wjg.v20.i40.14733

    Chemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancer (Journal article)

    Sultana, A., Jackson, R. J., Cox, T., Palmer, D., Neoptolemos, J., & Ghaneh, P. (n.d.). Chemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancer. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd011044

    DOI: 10.1002/14651858.cd011044

    A Robust Parameterization for Unbounded Covariates Within the Cox Proportional Hazards Model (Journal article)

    Jackson, R., & Cox, T. (2014). A Robust Parameterization for Unbounded Covariates Within theCox Proportional Hazards Model. International Journal of Statistics in Medical Research, 3, 331-339. Retrieved from http://dx.doi.org/10.6000/1929-6029.2014.03.04.1

    2013

    The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer (Journal article)

    Thornton, M., Aslam, M. A., Tweedle, E. M., Ang, C., Campbell, F., Jackson, R., . . . Boyd, M. T. (2013). The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer. International Journal of Cancer, 133(6), 1408-1418. doi:10.1002/ijc.28137

    DOI: 10.1002/ijc.28137

    2012

    Effect of specialist decision-making on treatment strategies for colorectal liver metastases (Journal article)

    Jones, R. P., Vauthey, J. -N., Adam, R., Rees, M., Berry, D., Jackson, R., . . . Malik, H. Z. (2012). Effect of specialist decision-making on treatment strategies for colorectal liver metastases. BRITISH JOURNAL OF SURGERY, 99(9), 1263-1269. doi:10.1002/bjs.8835

    DOI: 10.1002/bjs.8835

    Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 Trial (Journal article)

    Pettitt, A. R., Jackson, R., Carruthers, S., Dodd, J., Dodd, S., Oates, M., . . . Hillmen, P. (2012). Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 Trial. JOURNAL OF CLINICAL ONCOLOGY, 30(14), 1647-1655. doi:10.1200/JCO.2011.35.9695

    DOI: 10.1200/JCO.2011.35.9695

    GRP78: a novel biomarker for benefit from fluoropyrimidine-based (5-FU) adjuvant chemotherapy in colorectal cancer and determinant of 5-FU sensitivity in colorectal cancer cells (Journal article)

    Thornton, M., Boyd, M., Aslam, M., Tweedle, E., Ang, C., Campbell, F., . . . Rooney, P. (2012). GRP78: a novel biomarker for benefit from fluoropyrimidine-based (5-FU) adjuvant chemotherapy in colorectal cancer and determinant of 5-FU sensitivity in colorectal cancer cells. International Journal of Cancer.

    2011

    Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: Final results of the National Cancer Research Institute (NCRI) CLL206 Trial (Journal article)

    Pettitt, A. R., Jackson, R., Carruthers, S., Dodd, J., Dodd, S., Johnson, G. G., . . . Hillmen, P. (2011). Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: Final results of the National Cancer Research Institute (NCRI) CLL206 Trial. Journal of Clinical Oncology.

    Systematic review and meta-analysis of follow up after hepatectomy for colorectal liver metastases (Journal article)

    Jones, R. P., Dunne, D., Jackson, R., Fenwick, S., Malik, H., Poston, G., & Ghaneh, P. (2011). Systematic review and meta-analysis of follow up after hepatectomy for colorectal liver metastases. British Journal of Surgery.

    Undated

    Some statistical methods for the analysis of survival data in cancer clinical trials (Thesis / Dissertation)

    Jackson, R. (n.d.). Some statistical methods for the analysis of survival data in cancer clinical trials. (PhD Thesis, University of Liverpool).